OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
November 22, 2022
Webinar Date/Time: Mon, Dec 12, 2022 11:00 AM EST
November 21, 2022
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 14, 2022
The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.
Avantor is continuing its investment to support the biopharma market with the opening of its new distribution center in Dublin, Ireland.
Address needs for integrated, automated systems and service.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 03, 2022
Data analytics, modular equipment, digital tools, and risk-based validation improve speed, flexibility, and quality.
The state of oral solid dose manufacturing is influenced by new approaches, novel technologies, and the structural evolution of the raw materials market.
Adherence to detail and thorough project management are required for successful tech transfer and scale up.